Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients:
- People who are able to understand the purpose and risks of the registry and agree to participate by signing a consent form (or whose legal representative, such as a spouse or guardian, can do this on their behalf)
- People who have been diagnosed with Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), or early-stage dementia — including types such as Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease, Lewy-Body Dementia, and several other related conditions (confirm with trial site for the full list)
- People who have had specific brain-related biological tests done, such as spinal fluid measurements or brain scans that look at certain proteins linked to memory and brain health
- People aged 18 or older
For family members of patients:
- People aged 18 or older
- People whose family member is already enrolled in this registry
- People who are closely involved in the patient's daily life, as confirmed by the patient
- People who are able to understand the purpose and risks of the registry
Who may not be able to join:
For patients:
- People who are unwilling to sign a consent form agreeing to take part
- People who have not had the required biological tests — such as spinal fluid protein measurements or brain imaging scans — completed
For family members:
- People who are unable or unwilling to sign a consent form agreeing to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jörg B. Schulz, Prof. Dr., Department of Neurology, RWTH Aachen University Hospital
Phone: +49 241 80-89600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary objective is the development of a registry to collect longitudinal data on patients with cognitive impairment and dementia with fluid biomarkers in Germany.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.